Search for: "Eli Lilly "
Results 1241 - 1260
of 2,131
Sorted by Relevance
|
Sort by Date
18 Jul 2019, 5:43 am
Bart van WezenbeekThe scope of a patent is to be interpreted according to Art. 69 EPC and the Protocol. [read post]
19 Oct 2006, 7:29 pm
The Regulations Federal doctors now say drug maker Eli Lilly & Co. subtly influenced the development of medical guidelines for treatment of sepsis (an often fatal blood infection). [read post]
18 Nov 2009, 4:57 am
Eli Lilly & Co. [read post]
18 Nov 2009, 4:57 am
Eli Lilly & Co. [read post]
18 Nov 2009, 4:57 am
Eli Lilly & Co. [read post]
30 Aug 2016, 7:52 am
This report was co-written with chemist and IP enthusiast Benji Gibber, to whom this Kat is very grateful.DaptomycinThis case concerns three patents owned by the defendant Cubist Pharmaceuticals LLC relating to the antibiotic daptomycin, originally discovered by Eli Lilly in the 1980s. [read post]
27 Feb 2011, 5:37 pm
Eli Lilly, 598 F.3d 1336, 1354 (Fed. [read post]
7 Jun 2011, 11:06 am
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
27 Feb 2021, 5:21 am
Those who make it to paragraph [307] of the over 500 paragraph judgment are also rewarded with Mr Justice Birss' thought-provoking application of the doctrine of equivalents under Actavis v Eli Lilly ([2017] UKSC 48). [read post]
7 Aug 2012, 11:45 pm
In Eli Lilly & Co. v. [read post]
20 Mar 2008, 8:18 am
And in Eli Lilly & Co. v. [read post]
6 Oct 2010, 4:22 am
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated protein from B… [read post]
10 Aug 2010, 8:44 pm
General Coverage of anti-counterfeit policy debate varies widely across global media (IP Watch) WHO declares flu pandemic over; experts behind response to be revealed (IP Watch) Australia: TGA to implement alert system for new ARTG registrations (IP Whiteboard) EU: Final petition of the Advocate-General / Jodosulfuron- SPC for plant protection products (EPLAW) India: Parliamentary Committee on Health tables report on issues relating to availability of generic medicines (Spicy IP) Peru:… [read post]
3 Mar 2023, 12:01 am
Today, Eli Lilly did that,” Biden said in a statement. [read post]
19 Nov 2008, 1:16 pm
This particular drug is injected, which means that its cost to patients and our healthcare system are much greater – which also increases the incentive for aggressive marketing by the manufacturers, Eli Lilly and Amylin. [read post]
19 Dec 2008, 1:00 pm
(IP Kenya) UK: Damages for observing patent injunction: Les Laboratoires Servier & Anor v Apotex Inc & Ors (IP finance) US/China: ‘Eli Lilly lobbies on counterfeiting and regulatory issues involving China’ (IP Dragon) US: Federal judge dismisses patent lawsuit filed by Human Genome Sciences against Genentech over patent related to type of protein that can be used to detect tumours (Law360) US: MedImmune seeks invalidation of five patents owned by… [read post]
15 Sep 2010, 2:40 am
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP) US: PHOSITA:… [read post]
17 Aug 2011, 8:26 am
The litigation efforts will likely focus primarily on Xanodyne and Eli Lilly, as the drug companies responsible for the marketing and labeling for the brand name drugs. [read post]
3 Feb 2009, 3:22 pm
Darvon has been on the market since 1957, and was developed by Eli Lilly & Co. [read post]
17 Oct 2008, 1:32 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation… [read post]
